🧠 AI clinical summary is being generated for this article and will appear shortly.
Source: MHRA  ·  Read original ↗

The Commission on Human Medicines (CHM) has endorsed changes to isotretinoin prescribing guidance. In addition, CHM is seeking further information from dermatology services who prescribe isotretinoin to inform any future cha…


This content is sourced from MHRA and reproduced for clinical reference. ClinicalIQ does not alter source content.

Share: 𝕏 Twitter/X 🔗 LinkedIn View on MHRA ↗

More in Dermatology